Results 81 to 90 of about 8,312 (217)

An autopsy case of suspected anti-N-methyl-D-aspartate receptor encephalitis

Journal of Forensic Science and Medicine, 2019
N-methyl-D-aspartate receptor (NMDAR) encephalitis is a rare type of autoimmune limbic encephalitis. Herein, we report an autopsy case of highly suspected anti-NMDAR encephalitis, based on the patient's past psychiatric history and autopsy findings of ...
Kino Hayashi, Wakako Hikiji, Yohsuke Makino, Hisaomi Suzuki   +3 more
doaj   +1 more source

Ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis, a type of limbic encephalitis: a review of the literature and a case report in Korea

Clinical and Experimental Obstetrics & Gynecology, 2020
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a type of limbic encephalitis that is resulted by an autoimmune processes; it is a rare autoimmune encephalitis caused by the NMDA receptor antibody secreted by all kinds of tumors.
S.H. Park, J. Lim, K.T. Lim, K.H. Choi, S.M. Yoon, H.J. Chung   +5 more
doaj   +1 more source

Limbic Encephalitis and Related Cortical Syndromes

Current Treatment Options in Neurology, 2012
Patients with limbic encephalitis and related cortical syndromes develop neurologic and psychiatric symptoms due to autoimmune damage of limbic and extralimbic brain areas. Some patients develop limbic encephalitis as a paraneoplastic manifestation of systemic cancer, where immune tolerance is thought to be lost.
Miguel Salavert, Luis Bataller, Ignacio Rubio-Agusti   +2 more
openaire   +4 more sources

Treatment outcomes for equine osteoarthritis with mesenchymal stromal cells and hyaluronic acid

Equine Veterinary Journal, EarlyView.
Abstract Background Mesenchymal stromal cells (MSCs) are widely used to treat osteoarthritis (OA). Optimising dose, timing, and safety while comparing efficacy with standard therapies like hyaluronic acid (HA) is essential for their standardisation. Objectives To assess the safety and efficacy of equine umbilical cord‐derived (eCB) MSCs in client‐owned
Rodrigo Munevar Luque, Bri Henderson, Terence Connor McCorkell, Amir Hamed Alizadeh, Keith A. Russell, Thomas G. Koch, Judith Koenig   +6 more
wiley   +1 more source

Narcolepsy and rapid eye movement sleep

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini, Lucie Barateau, Fabio Pizza, Giuseppe Plazzi, Yves Dauvilliers   +4 more
wiley   +1 more source

Case report: Overlapping anti-AMPAR encephalitis with anti-IgLON5 disease post herpes simplex virus encephalitis

Frontiers in Immunology
Autoimmune encephalitis (AE) is the result of an autoimmune process that occurs as a rapidly advancing encephalopathy. Autoimmune encephalitis was commonly linked to herpes simplex virus 1 (HSV-1) as the most frequently identified virus.
Shihui Sun, Jiafeng Ren, Zhao Zhong, Xuxia Ma, Danqing Shang, Changjun Su, Xianchao Zhao   +6 more
doaj   +1 more source

Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis

Epilepsy and Behavior Case Reports, 2014
Importance: Anti-N-methyl-d-aspartate receptor (anti-NMDAR) autoimmune encephalitis is an increasingly recognized cause of limbic encephalitis (LE). Prolonged LE and limbic status epilepticus (LSE) share many features.
John C. Probasco, David R. Benavides, Anthony Ciarallo, Beatriz Wills Sanin, Angela Wabulya, Gregory K. Bergey, Peter W. Kaplan   +6 more
doaj   +1 more source

The Future of Parasomnias

Journal of Sleep Research, EarlyView.
ABSTRACT Parasomnias are abnormal behaviours or mental experiences during sleep or the sleep–wake transition. As disorders of arousal (DOA) or REM sleep behaviour disorder (RBD) can be difficult to capture in the sleep laboratory and may need to be diagnosed in large communities, new home diagnostic devices are being developed, including actigraphy ...
Claudia Picard‐Deland, Matteo Cesari, Ambra Stefani, Jean‐Baptiste Maranci, Birgit Hogl, Isabelle Arnulf   +5 more
wiley   +1 more source

Diagnostic performance of plasma p‐tau217 and Aβ42/40 biomarkers in the outpatient memory clinic

Alzheimer's &Dementia, Volume 21, Issue 6, June 2025.
Abstract INTRODUCTION Plasma biomarkers of Alzheimer's disease (AD) represent accessible alternatives to positron emission tomography (PET) and cerebrospinal fluid (CSF)‐based biomarkers in well‐characterized cohorts. It remains to be determined whether performance is maintained in outpatient clinics comprised of patients with multiple causes of ...
Yoav D. Piura, Daniel J. Figdore, Christian Lachner, Joshua Bornhorst, Alicia Algeciras‐Schimnich, Neill R. Graff‐Radford, Gregory S. Day   +6 more
wiley   +1 more source

Benzodiazepine and Opioid Withdrawal Induced Neuroleptic Malignant Like Syndrome: A Clinical Case Report With Management Complexities

Neuropsychopharmacology Reports, Volume 45, Issue 2, June 2025.
This case report describes a 54‐year‐old man who developed Neuroleptic Malignant‐like Syndrome (NMLS) following the abrupt withdrawal of high‐dose benzodiazepines and opioids. The report highlights the diagnostic challenges in differentiating NMLS from Neuroleptic Malignant Syndrome and emphasizes the critical role of GABAergic dysregulation in its ...
Behnam Abbasi, Forouzan Elyasi, Fateme Heydari, Roya Ghasemian   +3 more
wiley   +1 more source